RuiYi declares $15M Series B financing to advance monoclonal antibodies ... News-Medical.net RuiYi, Inc. announced today a $15 million Series B financing by existing investors: 5AM Ventures, Versant Ventures, Apposite Capital, SR One, the independent corporate healthcare venture capital fund of GlaxoSmithKline, Merck Serono Ventures, the ... RuiYi Raises $15M For Monoclonal Antibody Research RuiYi Announces $15 Million Series B to Advance Pipeline of Therapeutic ... |
